UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

5613127 PHARMACOKINETICS AND PHARMACODYNAMICS OF AN INNOVATIVE ORAL FORMULATION OF DECITABINE AND TETRAHYDROURIDINE IN HEALTHY PEOPLE

HemaSphere, 2023-04, Vol.7 (S1), p.16-16

2023

Link zum Volltext

Verfügbarkeit prüfen

Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies

Leukemia, 2013-06, Vol.27 (6), p.1301-1309

2013

Link zum Volltext

Verfügbarkeit prüfen

CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors

Leukemia, 2012-02, Vol.26 (2), p.244-254

2012

Link zum Volltext

Verfügbarkeit prüfen

The LSD1 inhibitor RN-1 recapitulates the fetal pattern of hemoglobin synthesis in baboons (P. anubis)

Haematologica (Roma), 2016-06, Vol.101 (6), p.688

2016

Link zum Volltext

Verfügbarkeit prüfen

Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron

Leukemia, 2015-01, Vol.29 (1), p.188-195

2015

Link zum Volltext

Verfügbarkeit prüfen

A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome

Blood, 2003-10, Vol.102 (8), p.3025-3027

2003

Link zum Volltext

Verfügbarkeit prüfen

p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia

Leukemia, 2011-11, Vol.25 (11), p.1739-1750

2011

Link zum Volltext

Verfügbarkeit prüfen

CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors

Leukemia, 2012-07, Vol.26 (7), p.1547-1554

2012

Link zum Volltext

Verfügbarkeit prüfen

Runx1 deficiency permits granulocyte lineage commitment but impairs subsequent maturation

Oncogenesis (New York, NY), 2013-11, Vol.2 (11), p.e78-e78

2013

Link zum Volltext

Verfügbarkeit prüfen

310 RISK OF BONE MARROW FAILURE CONDITIONS IN PATIENTS UNDERGOING INVASIVE CARDIAC PROCEDURES

Leukemia research, 2015-04, Vol.39, p.S154-S154

2015

Link zum Volltext

Verfügbarkeit prüfen

P-010 Distinct methylation signature in MDS patients with SF3B1 mutations confers a novel mechanism of disease pathogenesis

Leukemia research, 2013-05, Vol.37, p.S27-S27

2013

Link zum Volltext

Verfügbarkeit prüfen

Differences in Iron Distribution in Patients with Myelodysplastic Syndromes Carrying SF3B1 Mutations Using Energy-dispersive X-ray Spectroscopy (XEDS) and Electron-Energy Loss Spectroscopy (EELS)

Microscopy and microanalysis, 2013-08, Vol.19 (S2), p.234-235

2013

Link zum Volltext

Verfügbarkeit prüfen

5613127 PHARMACOKINETICS AND PHARMACODYNAMICS OF AN INNOVATIVE ORAL FORMULATION OF DECITABINE AND TETRAHYDROURIDINE IN HEALTHY PEOPLE

HemaSphere, 2023-04, Vol.7, p.16-16

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment

JAMA : the journal of the American Medical Association, 2003-04, Vol.289 (13), p.1645

2003

Link zum Volltext

Verfügbarkeit prüfen

Modification of hematopoietic stem cell fate by 5aza 2′deoxycytidine and trichostatin A

Blood, 2004-06, Vol.103 (11), p.4102-4110

2004

Link zum Volltext

Verfügbarkeit prüfen

Advances in experimental treatment of β-thalassaemia

Expert opinion on investigational drugs, 2001-05, Vol.10 (5), p.925-934

2001

Link zum Volltext

Verfügbarkeit prüfen

Critical Updates to the Leukemia Stem Cell Model

Cancer Stem Cells : Targeting the Roots of Cancer, Seeds of Metastasis, and Sources of Therapy Resistance, 2016, p.101-119

Saunthararajah, Y

2016

Link zum Volltext

Verfügbarkeit prüfen

HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome

Blood, 2002-09, Vol.100 (5), p.1570-1574

2002

Link zum Volltext

Verfügbarkeit prüfen

EVI1 induces myelodysplastic syndrome in mice

The Journal of clinical investigation, 2004-09, Vol.114 (5), p.713-719

2004

Link zum Volltext

Verfügbarkeit prüfen

Myelodysplastic syndrome and aplastic anemia: Distinct entities or diseases linked by a common pathophysiology?

Seminars in hematology, 2000, Vol.37 (1), p.15-29

2000

Link zum Volltext

Verfügbarkeit prüfen

Normal and transforming functions of RUNX1: A perspective

Journal of cellular physiology, 2006-06, Vol.207 (3), p.582-593

2006

Link zum Volltext

Verfügbarkeit prüfen

DNA hypo‐methylating agents and sickle cell disease

British journal of haematology, 2004-09, Vol.126 (5), p.629-636

2004

Link zum Volltext

Verfügbarkeit prüfen

Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells

Cancer research (Chicago, Ill.), 1999-06, Vol.59 (12), p.2766-2769

1999

Link zum Volltext

Verfügbarkeit prüfen

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome

Blood, 2001-12, Vol.98 (13), p.3513-3519

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(43)
Buchkapitel
(2)

Sprache

Englisch
(45)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Humans
(22)
Hematology
(16)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Oncology
(11)
Animals
(9)
Hematologic And Hematopoietic Diseases
(9)
Leukemia
(8)
Genetic Aspects
(7)
Mutation
(7)
Mice
(6)
Azacitidine - Therapeutic Use
(5)
Cancer
(5)
Myelodysplastic Syndromes
(5)
Stem Cells
(5)
Acute Myeloid Leukemia
(4)
Adult
(4)
Anemias. Hemoglobinopathies
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

5613127 PHARMACOKINETICS AND PHARMACODYNAMICS OF AN INNOVATIVE ORAL FORMULATION OF DECITABINE AND TETRAHYDROURIDINE IN HEALTHY PEOPLE

Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies

CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors

The LSD1 inhibitor RN-1 recapitulates the fetal pattern of hemoglobin synthesis in baboons (P. anubis)

Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron

A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome

p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia

CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors

Dynamics of clonal evolution in myelodysplastic syndromes

Runx1 deficiency permits granulocyte lineage commitment but impairs subsequent maturation

310 RISK OF BONE MARROW FAILURE CONDITIONS IN PATIENTS UNDERGOING INVASIVE CARDIAC PROCEDURES

P-010 Distinct methylation signature in MDS patients with SF3B1 mutations confers a novel mechanism of disease pathogenesis

Differences in Iron Distribution in Patients with Myelodysplastic Syndromes Carrying SF3B1 Mutations Using Energy-dispersive X-ray Spectroscopy (XEDS) and Electron-Energy Loss Spectroscopy (EELS)

5613127 PHARMACOKINETICS AND PHARMACODYNAMICS OF AN INNOVATIVE ORAL FORMULATION OF DECITABINE AND TETRAHYDROURIDINE IN HEALTHY PEOPLE

Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment

Modification of hematopoietic stem cell fate by 5aza 2′deoxycytidine and trichostatin A

Advances in experimental treatment of β-thalassaemia

Critical Updates to the Leukemia Stem Cell Model

HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome

EVI1 induces myelodysplastic syndrome in mice

Myelodysplastic syndrome and aplastic anemia: Distinct entities or diseases linked by a common pathophysiology?

Normal and transforming functions of RUNX1: A perspective

DNA hypo‐methylating agents and sickle cell disease

Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome

Aktive Filter

Suchergebnisse filtern